Positron-Emission Tomography
"Positron-Emission Tomography" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An imaging technique using compounds labelled with short-lived positron-emitting radionuclides (such as carbon-11, nitrogen-13, oxygen-15 and fluorine-18) to measure cell metabolism. It has been useful in study of soft tissues such as CANCER; CARDIOVASCULAR SYSTEM; and brain. SINGLE-PHOTON EMISSION-COMPUTED TOMOGRAPHY is closely related to positron emission tomography, but uses isotopes with longer half-lives and resolution is lower.
Descriptor ID |
D049268
|
MeSH Number(s) |
E01.370.350.350.800.700 E01.370.350.600.350.800.399 E01.370.350.710.800.399 E01.370.350.825.800.399 E01.370.384.730.800.399
|
Concept/Terms |
Positron-Emission Tomography- Positron-Emission Tomography
- Positron Emission Tomography
- PET Scan
- PET Scans
- Scan, PET
- Scans, PET
- Tomography, Positron-Emission
- Tomography, Positron Emission
|
Below are MeSH descriptors whose meaning is more general than "Positron-Emission Tomography".
Below are MeSH descriptors whose meaning is more specific than "Positron-Emission Tomography".
This graph shows the total number of publications written about "Positron-Emission Tomography" by people in this website by year, and whether "Positron-Emission Tomography" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 1 | 2 | 3 | 2005 | 1 | 6 | 7 | 2006 | 3 | 6 | 9 | 2007 | 2 | 8 | 10 | 2008 | 2 | 0 | 2 | 2009 | 3 | 5 | 8 | 2010 | 7 | 4 | 11 | 2011 | 2 | 9 | 11 | 2012 | 9 | 5 | 14 | 2013 | 5 | 14 | 19 | 2014 | 8 | 8 | 16 | 2015 | 5 | 11 | 16 | 2016 | 9 | 6 | 15 | 2017 | 2 | 3 | 5 | 2018 | 3 | 3 | 6 | 2019 | 0 | 3 | 3 | 2020 | 2 | 5 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Positron-Emission Tomography" by people in Profiles.
-
Schöder H, Polley MC, Knopp MV, Hall N, Kostakoglu L, Zhang J, Higley HR, Kelloff G, Liu H, Zelenetz AD, Cheson BD, Wagner-Johnston N, Kahl BS, Friedberg JW, Hsi ED, Leonard JP, Schwartz LH, Wilson WH, Bartlett NL. Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial. Blood. 2020 06 18; 135(25):2224-2234.
-
Chang JW, Bhuiyan M, Tsai HM, Zhang HJ, Li G, Fathi S, McCutcheon DC, Leoni L, Freifelder R, Chen CT, Moellering RE. In Vivo Imaging of the Tumor-Associated Enzyme NCEH1 with a Covalent PET Probe. Angew Chem Int Ed Engl. 2020 08 24; 59(35):15161-15165.
-
Parikh N, Pillai A. Positron Emission Tomography With Computed Tomography as a Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma: Ready for Prime Time? Liver Transpl. 2020 06; 26(6):746-747.
-
Waller J, Onderdonk B, Flood A, Swartz H, Shah J, Shah A, Aydogan B, Halpern H, Hasan Y. The clinical utility of imaging methods used to measure hypoxia in cervical cancer. Br J Radiol. 2020 Jul; 93(1111):20190640.
-
Platek A, Mix M, Chowdhry V, Farrugia M, Lacombe MA, Bogart JA, Degraaf L, Iovoli A, Arshad H, Wooten K, Gupta V, Hicks WL, Platek ME, Hahn SS, Singh AK. Evaluation of radiation treatment volumes for unknown primaries of the head and neck in the era of FDG PET. PLoS One. 2020; 15(4):e0231042.
-
Akiyama S, Traboulsi C, Rai V, Rubin DT. Re: 18F-FDG PET-MR enterography in predicting histological active disease using the Nancy index in ulcerative colitis: a randomized controlled trial. Eur J Nucl Med Mol Imaging. 2020 09; 47(10):2247.
-
Catenacci DVT, Chase L, Lomnicki S, Karrison T, de Wilton Marsh R, Rampurwala MM, Narula S, Alpert L, Setia N, Xiao SY, Hart J, Siddiqui UD, Peterson B, Moore K, Kipping-Johnson K, Markevicius U, Gordon B, Allen K, Racette C, Maron SB, Liao CY, Polite BN, Kindler HL, Turaga K, Prachand VN, Roggin KK, Ferguson MK, Posner MC. Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial. JAMA Netw Open. 2020 02 05; 3(2):e1921290.
-
ACR Appropriateness Criteria® Penetrating Trauma-Lower Abdomen and Pelvis. J Am Coll Radiol. 2019 Nov; 16(11S):S392-S398.
-
Sanchez IM, DiTommaso LE, Tsoukas MM. Oral Kaposi Sarcoma. JAMA Dermatol. 2019 03 01; 155(3):370.
-
Fan AP, Khalighi MM, Guo J, Ishii Y, Rosenberg J, Wardak M, Park JH, Shen B, Holley D, Gandhi H, Haywood T, Singh P, Steinberg GK, Chin FT, Zaharchuk G. Identifying Hypoperfusion in Moyamoya Disease With Arterial Spin Labeling and an [15O]-Water Positron Emission Tomography/Magnetic Resonance Imaging Normative Database. Stroke. 2019 02; 50(2):373-380.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|